P2Y 2 R deletion ameliorates sialadenitis in IL-14α-transgenic mice.
Autor: | Woods LT; Department of Biochemistry, University of Missouri, Columbia, MO, USA.; Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO, USA., Camden JM; Department of Biochemistry, University of Missouri, Columbia, MO, USA.; Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO, USA., Khalafalla MG; Department of Biochemistry, University of Missouri, Columbia, MO, USA.; Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO, USA., Petris MJ; Department of Biochemistry, University of Missouri, Columbia, MO, USA.; Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.; Department of Nutritional Sciences and Exercise Physiology, University of Missouri, Columbia, MO, USA., Erb L; Department of Biochemistry, University of Missouri, Columbia, MO, USA.; Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO, USA., Ambrus JL Jr; Department of Medicine, Division of Allergy, Immunology and Rheumatology, SUNY at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA., Weisman GA; Department of Biochemistry, University of Missouri, Columbia, MO, USA.; Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Oral diseases [Oral Dis] 2018 Jul; Vol. 24 (5), pp. 761-771. Date of Electronic Publication: 2018 Mar 13. |
DOI: | 10.1111/odi.12823 |
Abstrakt: | Objective: Interleukin-14α-transgenic (IL-14αTG) mice develop an autoimmune exocrinopathy with characteristics similar to Sjögren's syndrome, including sialadenitis and hyposalivation. The P2Y Materials and Methods: IL-14αTG mice were bred with P2Y Results: Genetic ablation of P2Y Conclusions: The results of this study suggest that P2Y (© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |